<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04243447</url>
  </required_header>
  <id_info>
    <org_study_id>201909174</org_study_id>
    <nct_id>NCT04243447</nct_id>
  </id_info>
  <brief_title>Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery</brief_title>
  <acronym>DoD FAI-2</acronym>
  <official_title>Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>San Antonio Military Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>William Beaumont Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boca Raton Regional Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boston Childrenâ€™s Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CHU de Quebec-Universite Laval</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Twin Cities Orthopedics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Regents of the University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ottawa Hospital Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Case Western Reserve University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital of Eastern Ontario</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overarching goal of the study is to improve the surgical treatment outcomes of FAI, which
      is affecting an increasing number of military personnel and young active individuals in the
      general population. The proposed study will investigate critical patient, disease, and
      surgical treatment predictors of FAI surgery outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PROCEDURES:

      Potential participants will be identified at their initial PI's outpatient clinic at which
      the PI will meet with the patient and determine if the patient should be treated surgically
      due to a diagnosis of FAI. Once the PI identifies the patient as a surgical candidate, the
      research study team in the clinic will approach the patient with study information to
      discuss. If the patient would like to participate, the patient will sign an informed consent
      document (assent document for minors) and begin completing study-specific information. If the
      patient would like to take the study documents home to consider participation, the research
      team member will provide his/her contact information to the patient.

      SPECIFIC AIMS:

        1. Determine the predictors of mid-term patient-reported outcomes (PROs) and treatment
           failures in an established prospective longitudinal cohort of Femoroacetabular
           Impingement (FAI) surgeries.

        2. Determine the impact of three-dimensional femoral and acetabular morphology on PROs at
           short-term follow-up in a novel prospective longitudinal cohort of arthroscopic FAI
           surgery.

        3. Determine if the new Patient-Reported Outcome Measurement Information System (PROMIS)
           correlates with legacy PROs in patients undergoing FAI surgery.

      DATA COLLECTION:

        1. Retrospective Follow-up (FAI-1): The original cohort includes previously consented
           participants in a closed-to-enrollment study who underwent FAI surgical treatment in the
           past. This cohort will be followed to investigate the most important predictors of FAI
           surgery outcomes. In Specific Aim 1, we propose to analyze mid-term follow-up (minimum 8
           years) of the FAI-1 cohort to identify important predictors of treatment outcomes and
           failures in FAI surgery.

        2. Prospective Enrollment (FAI-2): Consented participants, in the actively enrolling study,
           will be enrolled in a new multicenter longitudinal prospective arthroscopic FAI surgery
           cohort and followed to a minimum 2 years post-surgery (T2). The primary outcome measures
           will be the collection of the patient report outcomes (PROs) that will be analyzed in
           order to improve surgical care and outcomes. These clinical outcome metrics will be
           assessed at baseline, 3 months, 6 month, 1 year, and 2 year postoperatively.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 2, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Hip disability and Osteoarthritis Outcome Score (HOOS)</measure>
    <time_frame>Pre operative (Baseline), change from baseline HOOS at 3 months, change from baseline HOOS at 6 months, change from baseline HOOS at 1 year, and change from baseline HOOS at 2 year.</time_frame>
    <description>HOOS is a questionnaire constructed to assess patient-relevant outcomes in five separate sub-scales (pain, symptoms, activity of daily living, sport and recreation function and hip-related quality of life). HOOS is scored 0-100 with higher scores being the best outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Short Form Health Survey (SF-12)</measure>
    <time_frame>Pre operative (Baseline), change from baseline SF-12 at 3 months, change from baseline SF-12 at 6 months, change from baseline SF-12 at 1 year, and change from baseline SF-12 at 2 year</time_frame>
    <description>The SF-12 is a shortened, validated, patient-reported survey of patient health with questions pulled directly from the longer form SF-36. SF-12 is scored 0-100 with higher scores being the best outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient-Reported Outcomes Measurement Information System (PROMIS) - Physical Function (PF)</measure>
    <time_frame>Pre operative (Baseline), change from baseline PROMIS - PF at 3 months, change from baseline PROMIS - PF at 6 months, change from baseline PROMIS -PF at 1 year, and change from baseline PROMIS - PF at 2 year</time_frame>
    <description>PROMIS is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults and children. It can be used with the general population and with individuals living with chronic conditions. This specific PROMIS survey assesses a patient's physical function. PROMIS - PF is scored from 14.7-75.6 with the higher scores being the best outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient-Reported Outcomes Measurement Information System (PROMIS) - Pain Interference (PI)</measure>
    <time_frame>Pre operative (Baseline), change from baseline PROMIS - PI at 3 months, change from baseline PROMIS - PI at 6 months, change from baseline PROMIS -PI at 1 year, and change from baseline PROMIS - PI at 2 year</time_frame>
    <description>PROMIS is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults and children. It can be used with the general population and with individuals living with chronic conditions. This specific PROMIS survey assesses a patient's pain interference. PROMIS - PI is scored from 38.7-83.8 with the lower scores being the best outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient-Reported Outcomes Measurement Information System (PROMIS) - Mobility (M)</measure>
    <time_frame>Pre operative (Baseline), change from baseline PROMIS - M at 3 months, change from baseline PROMIS - M at 6 months, change from baseline PROMIS -M at 1 year, and change from baseline PROMIS - M at 2 year</time_frame>
    <description>PROMIS is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults and children. It can be used with the general population and with individuals living with chronic conditions. This specific PROMIS survey assesses a patient's mobility. PROMIS - M is scored from 18.2-60.2 with the higher scores being the best outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression (D)</measure>
    <time_frame>Pre operative (Baseline), change from baseline PROMIS - D at 3 months, change from baseline PROMIS - D at 6 months, change from baseline PROMIS - D at 1 year, and change from baseline PROMIS - D at 2 year</time_frame>
    <description>PROMIS is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults and children. It can be used with the general population and with individuals living with chronic conditions. This specific PROMIS survey assesses a patient's depression. PROMIS - D is scored from 34.2-84.4 with the lower scores being the best outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety (A)</measure>
    <time_frame>Pre operative (Baseline), change from baseline PROMIS - A at 3 months, change from baseline PROMIS - A at 6 months, change from baseline PROMIS - A at 1 year, and change from baseline PROMIS - A at 2 year</time_frame>
    <description>PROMIS is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults and children. It can be used with the general population and with individuals living with chronic conditions. This specific PROMIS survey assesses a patient's anxiety. PROMIS - A is scored from 32.9-84.9 with the lower scores being the best outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Univeristy of California Los Angeles Activity Score (UCLA Score)</measure>
    <time_frame>Pre operative (Baseline), change from baseline UCLA Score at 3 months, change from baseline UCLA Score at 6 months, change from baseline UCLA Score at 1 year, and change from baseline UCLA Score at 2 year</time_frame>
    <description>UCLA Score represents a reliable tool for assessing the level of physical activity and the return to sport high functional demand after hip surgery. The UCLA Score is scored from 0-10 with higher scores being the best outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International Hip Outcome Tool (iHot-12)</measure>
    <time_frame>Pre operative (Baseline), change from baseline iHOT-12 at 3 months, change from baseline iHOT-12 at 6 months, change from baseline iHOT-12 at 1 year, and change from baseline iHOT-12 at 2 year</time_frame>
    <description>iHOT-12 is a validated 12-item short form of iHot-33. It was designed to measure the impact of hip disease in young, active patients and to measure the effect of treatment of this disease.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Harris Hip Score (mHHS)</measure>
    <time_frame>Pre operative (Baseline), change from baseline mHHS at 3 months, change from baseline mHHS at 6 months, change from baseline mHHS at 1 year, and change from baseline mHHS at 2 year</time_frame>
    <description>The mHHS is a reliable and valid tool for assessment of functional outcome, post total hip replacement in Indian patients, with a positive correlation with the standard Harris Hip Score. mHHS is scored 0-100 with higher scores being the best outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brief Resilience Scale (BRS)</measure>
    <time_frame>Pre operative (Baseline)</time_frame>
    <description>The BRS was created to assess the ability to bounce back or recover from stress.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Femoracetabular Impingement</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Skeletally mature patients being treated surgically for FAI after failing conservative
        treatment.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 14 - 40 years

          2. Skeletally Mature

          3. Failure of 6 weeks of conservative treatment

          4. Primary surgery (Hip Arthroscopic Treatment)

             a. Surgical treatment of FAI with hip arthroscopy

          5. Tonnis 0 -1 OA, with greater than 2 mm of joint space

          6. Clinical diagnosis of FAI (cam or combined; alpha &gt;50 degrees)

        Exclusion Criteria:

          1. Not a surgical candidate

          2. Skeletally Immature

          3. Acetabular Dysplasia (LCEA &lt; 20)

          4. Tonnis 2+ OA

          5. Previous ipsilateral hip surgery

          6. Previous major hip trauma (hip fractures, hip dislocations)

          7. Additional disease processes (e.g., Avascular Necrosis (AVN), synovial disease,
             Ehlers-Danlos Syndrome (EDS), neuromuscular disorders)

          8. Unable to consent due to mental faculty

          9. Pregnant women

         10. Non-English speaking patients

         11. Prisoners or other vulnerable populations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John C Clohisy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Caroline E Drain, MHS</last_name>
    <phone>314-747-2579</phone>
    <email>drain.caroline.e@wustl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zachary D Robben, MS</last_name>
    <phone>314-454-5345</phone>
    <email>zachary.robben@wustl.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>BocaCare Orthopedics</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33486</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pilar Zuniga</last_name>
      <email>Pzuniga@brrh.com</email>
    </contact>
    <investigator>
      <last_name>James R Ross, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>John Gentile</last_name>
      <phone>319-467-8328</phone>
      <email>armand-gentile@uiowa.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Westermann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lauren Hutchinson, MPH</last_name>
      <phone>617-355-4011</phone>
      <email>Lauren.Hutchinson@childrens.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Millis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Young-Jo Kim, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eduardo Novais, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yi-Meng Yen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bethany Ruffino</last_name>
      <phone>734-615-0768</phone>
      <email>bruffino@med.umich.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jaimee Gauthier</last_name>
      <email>jaimeeg@med.umich.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Asheesh Bedi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shalinee Mylvaganam, MS</last_name>
      <phone>248-551-0194</phone>
      <email>Shalinee.Mylvaganam@beaumont.org</email>
    </contact>
    <contact_backup>
      <last_name>Lisa Motowski</last_name>
      <phone>248-551-6679</phone>
      <email>lisa.motowski@beaumont.org</email>
    </contact_backup>
    <investigator>
      <last_name>Ira Zaltz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Twin Cities Orthopedics</name>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <zip>55435</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55902</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jonathan Furuseth</last_name>
      <email>furuseth.jonathan@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Makinzee Kazeck</last_name>
      <email>kazeck.makinzee@mayo.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Rafael Sierra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Trousdale, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bruce Levy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aaron Krych, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline E Drain, MHS</last_name>
      <phone>314-747-2579</phone>
      <email>drain.caroline.e@wustl.edu</email>
    </contact>
    <contact_backup>
      <last_name>Zachary D Robben, MS</last_name>
      <phone>314-454-5345</phone>
      <email>zachary.robben@wustl.edu</email>
    </contact_backup>
    <investigator>
      <last_name>John C Clohisy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeffrey J Nepple, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cecilia Pascual-Garrido, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Perry Schoenecker, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UH Cleveland (Case Western)</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Michael J Salata, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Scottish Rite Hospital for Children</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>San Antonio Military Medical Center</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dennis Mann</last_name>
      <phone>210-916-6685</phone>
      <email>dennis.w.mann.civ@mail.mil</email>
    </contact>
    <contact_backup>
      <last_name>Liza Summerfield</last_name>
      <phone>210-916-8592</phone>
      <email>lizabeth.m.summerfield.ctr@mail.mil</email>
    </contact_backup>
    <investigator>
      <last_name>Matthew Schmitz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Eastern Ontario</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>(+4) K1H 8L1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Holly Livock</last_name>
      <phone>613-737-7600</phone>
      <phone_ext>1360</phone_ext>
      <email>hlivock@cheo.on.ca</email>
    </contact>
    <investigator>
      <last_name>Sasha Carsen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ottawa Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cheryl Kreviazuk</last_name>
      <phone>613-737-8899</phone>
      <phone_ext>74710</phone_ext>
      <email>ckreviazuk@ohri.ca</email>
    </contact>
    <contact_backup>
      <last_name>Holly Livock</last_name>
      <phone>613-737-7600</phone>
      <phone_ext>4120</phone_ext>
      <email>hlivock@cheo.on.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Paule Beaule, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Geoffrey Wilkin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sasha Carsen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Quebec - Universite Laval</name>
      <address>
        <city>Quebec City</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sylvie Turmel</last_name>
      <phone>418-525-4444</phone>
      <phone_ext>66175</phone_ext>
      <email>turmel.sylvie@chudequebec.ca</email>
    </contact>
    <investigator>
      <last_name>Etienne Belzile, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>January 17, 2020</study_first_submitted>
  <study_first_submitted_qc>January 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2020</study_first_posted>
  <last_update_submitted>May 19, 2020</last_update_submitted>
  <last_update_submitted_qc>May 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Femoracetabular Impingement (FAI)</keyword>
  <keyword>Low-dose computed tomography (CT)</keyword>
  <keyword>Patient Reported Outcomes (PROs)</keyword>
  <keyword>Academic Network for Conservational Hip Outcomes Research (ANCHOR)</keyword>
  <keyword>Hip Arthroscopy</keyword>
  <keyword>Osteoarthritis (OA)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Femoracetabular Impingement</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

